Gene Therapy Latest News | Experimental Gene Therapy Studies

AMT-061 Increases FIX Activity, Reduces Bleeding in Phase 3 Trial, Data Show

20 November 2020

Pfizer and Sangamo Dose First Participant in Phase 3 Study Evaluating Hemophilia A Gene Therapy Treatment

09 October 2020

A reprieve from hemophilia A, but for how long?

13 October 2020

ISTH and EAHAD Announce Partnership on Educational Components of the ISTH Gene Therapy in Hemophilia Education Initiative

01 October 2020

Gene Therapy for Hemophilia: Anticipating the Unexpected
11 August 2020
Request for Proposals: Artificial Intelligence/Machine Learning Research in Hemophilia
06 August 2020
Gene Therapy BAY 2599023 Showing Steady FVIII Activity, Safety in Trial
24 July 2020
Spark Therapeutics Announces Updated Data on SPK-8011 from Phase 1/2 Clinical Trial in Hemophilia A at ISTH 2020 Virtual Congress
12 July 2020

I agree with the Terms and conditions and the Privacy policy

About

Supported by educational grants from BioMarin, Freeline Therapeutics Limited, Pfizer Inc., Shire, Spark Therapeutics, and uniQure, Inc

Essential SSL